* Immunocore Holdings PLC IMCR.OQ reported a quarterly
adjusted loss of 92 cents per share for the quarter ended
in March. The mean expectation of three analysts for the quarter
was for a loss of 81 cents per share.
* Revenue was $9.96 million; analysts expected $10.04
million.
* Immunocore Holdings PLC's reported EPS for the quarter was a
loss of 92 cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Immunocore Holdings PLC shares had fallen by 2.8% this
quarter.
* The company reported a quarterly loss of $34.98 million.
* Wall Street's median 12-month price target for Immunocore
Holdings PLC is $51.50
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated May 12 at 03:07 p.m. GMT.
All figures in US dollars